Are Vemurafenib and Vemurafenib the same medicine?

Vemurafenib (Vemurafenib) Vemurafenib is the same drug. Vemurafenib is indicated for the treatment of patients with unresectable or metastatic melanoma who have a BRAF V600E mutation identified by a U.S. Food and Drug Administration (FDA)-approved test and patients with Erdheim-Chester disease who have a BRAF V600 mutation. Vemurafenib has been shown to be effective in prolonging patients' lives and delaying disease progression. One study showed that patients taking vemurafenib survived an average of 13.2 months. After being launched on the market, the research drug has many names such as Vemurafenib tablets, Vemurafenib, Vemurafenib, Vemurafenib, Vemurafenib, etc. It may be sold under the name Zelboraf overseas and Zelboraf domestically.